Clinical value of circulating tumor cells in metastatic breast cancerNikos Xenidis
1) Circulating tumor cells (CTCs) in patients with metastatic breast cancer provide important clinical information and can help guide treatment decisions. The number of CTCs before and during therapy correlates with progression-free and overall survival.
2) Molecular characterization of CTCs can reveal discordance between primary tumors and metastases, as well as heterogeneity within metastatic sites, helping to identify appropriate targeted therapies. Serial CTC analysis during treatment can detect emerging resistance mutations.
3) Monitoring changes in CTC counts during therapy provides an early indicator of treatment effectiveness compared to imaging, and may help determine when to switch treatments for better outcomes.
This document summarizes a study that analyzed whole transcriptome profiles of patient-derived xenograft (PDX) models of various cancer types using RNA sequencing. Specifically:
- Human tumor cells from 79 patients with cancers like breast, lung, GI, ovarian and leukemia were implanted in mouse models. RNA from both human tumor and mouse stromal cells was extracted and analyzed.
- Unsupervised analysis identified batch effects across samples and specific samples with high stromal or cancer expression. This helped distinguish tumor vs stromal signals and identify potential biomarkers.
- The study aims to better understand the relationship between human tumors and mouse stroma in PDX models and identify biomarkers for personalized cancer treatment.
This study analyzed omics data from over 70 breast cancer cell lines to develop predictive signatures of drug response. Pretreatment measurements included mRNA expression, copy number, protein expression, gene mutations, and transcriptome and methylation assays. Machine learning algorithms were used to identify associations between biological responses to therapy and pretreatment signatures. The developed signatures could predict drug response probabilities and help inform precision treatment recommendations for breast cancer patients. However, cell lines do not capture the full tumor microenvironment impacting response.
Cancer gwas and genetic risk predictionDavid Enoma
Genome wide association studes and its application in cancer as well as genetic risk prediction scoring for cancers. Especially in populations of African ancestry.
This document compares risk factors and molecular analysis of right-sided colon cancer and left-sided colon cancer. It discusses that:
- Right-sided colon cancer predominantly follows a MSI pathway while left-sided colon cancer follows a CIN pathway.
- There are differences in the embryonic development, function, and gene expression between the right and left colon that influence cancer risk.
- Certain risk factors like family history, inflammatory bowel disease, diet, and geographic location are associated with increased rates of either right-sided or left-sided colon cancers.
A germline mutation in the brca1 3'utr predicts stage iv breast cancerDavid W. Salzman
1) A variant in the 3' untranslated region (3'UTR) of the BRCA1 gene was found to predict increased risk of stage IV breast cancer.
2) In vitro luciferase assays showed the variant reduced BRCA1 expression and altered response to stimuli compared to the normal 3'UTR.
3) Analysis of breast tumor tissue found reduced BRCA1 expression in patients with the variant, and patients with the variant had a 4-fold increased risk of stage IV disease.
This document discusses new classifications of colorectal cancer based on molecular markers and gene expression profiling. It summarizes that traditional staging is not enough to predict outcomes or therapy responses, as cancer is heterogeneous. Early classifications used markers like microsatellite instability, DNA methylation and mutations in genes like KRAS and BRAF, identifying subtypes, but had significant overlap. New research using genomic techniques like microarrays now allows a robust classification of colorectal cancer into four consensus molecular subtypes, providing a basis for personalized treatment.
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...UCLA
The KRAS-variant may be a genetic marker of risk for type 2 endometrial cancers. In addition, tumor miRNA expression appears to be associated with patient age, lymphovascular invasion and the KRAS-variant, supporting the hypothesis that altered tumor biology can be measured by miRNA expression, and that the KRAS-variant likely impacts endometrial tumor biology.
Clinical value of circulating tumor cells in metastatic breast cancerNikos Xenidis
1) Circulating tumor cells (CTCs) in patients with metastatic breast cancer provide important clinical information and can help guide treatment decisions. The number of CTCs before and during therapy correlates with progression-free and overall survival.
2) Molecular characterization of CTCs can reveal discordance between primary tumors and metastases, as well as heterogeneity within metastatic sites, helping to identify appropriate targeted therapies. Serial CTC analysis during treatment can detect emerging resistance mutations.
3) Monitoring changes in CTC counts during therapy provides an early indicator of treatment effectiveness compared to imaging, and may help determine when to switch treatments for better outcomes.
This document summarizes a study that analyzed whole transcriptome profiles of patient-derived xenograft (PDX) models of various cancer types using RNA sequencing. Specifically:
- Human tumor cells from 79 patients with cancers like breast, lung, GI, ovarian and leukemia were implanted in mouse models. RNA from both human tumor and mouse stromal cells was extracted and analyzed.
- Unsupervised analysis identified batch effects across samples and specific samples with high stromal or cancer expression. This helped distinguish tumor vs stromal signals and identify potential biomarkers.
- The study aims to better understand the relationship between human tumors and mouse stroma in PDX models and identify biomarkers for personalized cancer treatment.
This study analyzed omics data from over 70 breast cancer cell lines to develop predictive signatures of drug response. Pretreatment measurements included mRNA expression, copy number, protein expression, gene mutations, and transcriptome and methylation assays. Machine learning algorithms were used to identify associations between biological responses to therapy and pretreatment signatures. The developed signatures could predict drug response probabilities and help inform precision treatment recommendations for breast cancer patients. However, cell lines do not capture the full tumor microenvironment impacting response.
Cancer gwas and genetic risk predictionDavid Enoma
Genome wide association studes and its application in cancer as well as genetic risk prediction scoring for cancers. Especially in populations of African ancestry.
This document compares risk factors and molecular analysis of right-sided colon cancer and left-sided colon cancer. It discusses that:
- Right-sided colon cancer predominantly follows a MSI pathway while left-sided colon cancer follows a CIN pathway.
- There are differences in the embryonic development, function, and gene expression between the right and left colon that influence cancer risk.
- Certain risk factors like family history, inflammatory bowel disease, diet, and geographic location are associated with increased rates of either right-sided or left-sided colon cancers.
A germline mutation in the brca1 3'utr predicts stage iv breast cancerDavid W. Salzman
1) A variant in the 3' untranslated region (3'UTR) of the BRCA1 gene was found to predict increased risk of stage IV breast cancer.
2) In vitro luciferase assays showed the variant reduced BRCA1 expression and altered response to stimuli compared to the normal 3'UTR.
3) Analysis of breast tumor tissue found reduced BRCA1 expression in patients with the variant, and patients with the variant had a 4-fold increased risk of stage IV disease.
This document discusses new classifications of colorectal cancer based on molecular markers and gene expression profiling. It summarizes that traditional staging is not enough to predict outcomes or therapy responses, as cancer is heterogeneous. Early classifications used markers like microsatellite instability, DNA methylation and mutations in genes like KRAS and BRAF, identifying subtypes, but had significant overlap. New research using genomic techniques like microarrays now allows a robust classification of colorectal cancer into four consensus molecular subtypes, providing a basis for personalized treatment.
The KRAS-Variant and miRNA Expression in RTOG Endometrial Cancer Clinical Tri...UCLA
The KRAS-variant may be a genetic marker of risk for type 2 endometrial cancers. In addition, tumor miRNA expression appears to be associated with patient age, lymphovascular invasion and the KRAS-variant, supporting the hypothesis that altered tumor biology can be measured by miRNA expression, and that the KRAS-variant likely impacts endometrial tumor biology.
This document summarizes three papers on population genetics and genomics research in African populations. The first paper discusses the African Genome Variation Project, which characterized genetic diversity in Africa and improved genomic studies on the continent. The second paper reviews pharmacogenetics studies in African populations, finding relatively few but highlighting their importance. The third paper summarizes prostate cancer genome-wide association studies, including initial studies identifying risk loci and more recent work identifying additional variants in African populations.
The document provides an overview of the history and development of oncology. It discusses how cancer was first documented in ancient Egypt and treated by cauterization. It then covers key developments like Hippocrates naming cancer, the first autopsy being performed in 1761, and the establishment of the TNM staging system. The summary concludes by briefly mentioning common modern cancer treatment modalities like surgery, radiation therapy, chemotherapy, and their goals of cure, palliation, or prevention.
Histopathological Patterns of Germ Cell Tumours of Ovary in a Tertiary Level ...inventionjournals
This document summarizes research on histopathological patterns of germ cell tumors of the ovary. The study found that benign cystic teratomas (dermoid cysts) made up the highest percentage at 26.47%, followed by dysgerminoma at 1.96%, immature teratoma at 0.98%, and yolk sac tumor at 0.98%. Germ cell tumors are more common in younger patients and can be benign or malignant. The histopathological patterns and characteristics of various germ cell tumors are described, including dysgerminoma, yolk sac tumor, embryonal carcinoma, polyembryoma, choriocarcinoma, and teratomas. Tumor markers such
This document summarizes research on Cadm1, a gene that suppresses metastasis. Genetic analysis identified a locus on mouse chromosome 9 associated with metastasis. Cadm1 was validated as a metastasis-suppressing gene within this locus. Ectopic expression of Cadm1 reduced pulmonary metastasis in vivo, while knockdown increased metastasis. Cadm1 expression was associated with better survival in human breast cancer datasets. The mechanism of Cadm1's effect involves interaction with the cell-mediated immune system through proteins like CRTAM that activate CD8+ T cells and NK cells, reducing metastasis in an immune-dependent manner.
We describe a comprehensive genomic characterization of 91 adrenocortical carcinoma specimens. Analysis identified several new ACC driver genes including PRKAR1A, RPL22, TERF2, CCNE1, and NF1. Genome-wide analysis revealed frequent occurrence of massive DNA loss followed by whole-genome doubling (WGD), associated with aggressive disease. WGD was identified as a hallmark of ACC progression, supported by increased TERT expression, decreased telomere length, and cell-cycle activation. Integrated molecular subtyping identified three ACC subtypes with distinct clinical outcomes and alterations, which could be captured by a 68-CpG DNA-methylation signature for clinical stratification.
This study used high-density SNP microarrays to analyze chromosomal changes in 86 paired colorectal cancer and normal tissue samples from Bangladeshi patients. The researchers identified common regions of amplification on chromosomes 20q, 13q, 8q, and 5p and deletions on 18q, 17p, and 8p. They also detected mosaicism and different types of chromosomal abnormalities that could not be assessed by other methods. By matching genes in altered regions to drug databases, the researchers identified potential targeted therapies for personalized treatment based on a patient's cytogenetic profile. This represents an application of high-density SNP arrays for colorectal cancer cytogenetics and personalized treatment approaches.
The document discusses molecular testing for breast cancer. It describes how molecular testing can provide insights into breast cancer subtypes, predict response to treatments, and assess recurrence risk. Several molecular tests are discussed, including Oncotype DX, Mammaprint, Prosigna, and tumor sequencing to identify actionable mutations. Molecular profiling is becoming increasingly important for personalized prevention, diagnosis, and treatment of breast cancer.
Over the past century, cancer treatment and outcomes have significantly improved due to advances in chemotherapy, radiation therapy, screening, surgery, and targeted molecular therapies. Five-year survival rates for many cancers have doubled or tripled compared to the 1970s. Recent decades have seen the development of targeted drugs, genomic mapping, and vaccines to prevent certain cancers. There are now over 13 million cancer survivors in the US, compared to just 3 million in the 1970s, demonstrating major gains against cancer.
This document summarizes a study that used DNA microarrays to analyze gene expression patterns in ovarian carcinomas. The key findings include:
1) The study identified groups of genes that distinguished clear cell ovarian carcinomas from other subtypes, and low-grade from high-grade serous papillary carcinomas.
2) Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas based on their gene expression patterns.
3) A comparison of ovarian carcinomas to breast cancers revealed 62 genes that correctly classified all 125 specimens, with genes like PAX8, mesothelin, and ephrin-B1 more highly expressed in ovarian carcinomas.
This document summarizes research targeting metastatic triple negative breast cancer using phage display nanotechnology. Key points:
- Triple negative breast cancer, which lacks estrogen, progesterone and HER2 receptors, has poor survival rates and few treatment options. The goal is to target cancer stem cells that initiate metastases.
- Phage display was used to select peptide sequences that bind specifically to triple negative breast cancer cells. Over 3 rounds of selection and amplification, binding peptides were increasingly enriched.
- Isolated phage clones were sequenced to identify binding peptide sequences for further development of targeted nanomedicines to treat metastatic triple negative breast cancer. Future work will modify pre-existing cancer nanomedicines with the selected peptides.
Breast cancer is the most common cancer among women in different societies. Because life is constructed evolutionary on the gravity of ‘g’, removed gravity as a variable can lead to clarify many biologic questions. Today, the weightlessness is a new method to study cellular changes. Weightlessness leads to metabolic and functional changes of the human body, and studies have shown that weightlessness leads to changes in growth and gene expression in cancer cells. The aim of this study is to evaluate the effect of weightlessness on apoptosis and cellular cycle in breast cancer cells. The tests of Annexin-V, PI-flow cytometer, and MTT have been used here. Cells of the weightlessness group are cultured on Clinostat prepared by the United Nations, and in gravity of 0.001g. The cell death and apoptosis using Annexin kit, and cell cycle using the PI and flow cytometer were investigated. Also, the amount of cell damage was determined by MTT. The apoptosis results showed that weightlessness leads to a reduction of 40% in apoptosis in cell line MCF-7, and the increase in BT-20 cell line for two times. Apoptosis in cell line MDA-MB-468 was not affected, and the results showed that the cell cycle and growth in cell line ZR-75 increased at a rate of five times (35% of weightlessness group versus 7% of control). Cell growth in the other categories showed no significant difference between two groups. Also, no significant difference was observed in the amounts of cell damage in groups of weightlessness and control.
The most complete map of oncogenes to date a summary of 568 oncogenes in 66 c...DoriaFang
By analyzing the genomes of 28,076 tumor samples from 66 types of cancer, 568 cancer driver genes were identified. This is the most complete map of cancer driver genes to date. The research data has been updated on the IntOGen platform.
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
MSC CM suppresses epithelial ovarian cancer cells in vitro in a concentration-dependent manner. When ovarian cancer cells were treated with MSC CM at concentrations of 100%, 75%, 50%, and 25% for 72 hours, cell morphology changes were observed including cell shrinkage, debris and reduced cell numbers compared to control. MTT assays showed reduced proliferation and Annexin V testing demonstrated increased early and late apoptosis. Cell cycle analysis found an increased sub-G1 phase, indicating apoptosis. Expression of embryonic stemness genes was also progressively suppressed in cancer cells treated with MSC CM compared to control. Therefore, MSC CM has potential as an ovarian cancer inhibitor by creating new treatment modalities.
The study compared gene expression profiles between breast and prostate tumor stromas using microarray data and gene set enrichment analysis (GSEA). GSEA identified pathways that were commonly up-regulated or down-regulated in both tumor stromas, as well as pathways that were differentially regulated between them. Specifically, 9 pathways showed common regulation, while others like ABC transporters and oxidative phosphorylation differed in their regulation between tumor types. Certain genes and transcription factors also demonstrated heterogeneous expression patterns between breast and prostate tumor stroma. The results reveal genomic heterogeneity between tumor microenvironments and identify candidate signatures relevant to cancer progression.
The study aimed to analyze the molecular profiles of surgical margins and colorectal cancer (CRC) tumors to identify prognostic markers. The results showed that cancer stem-like cells (CSCs) were present in 84.84% of tumors but also enriched in the distal surgical margin in 63.63% of cases. CSCs in distal margins correlated with shorter resection lengths, with 81.8% of margins under 2cm positive for CSCs compared to 0% over 5cm. Additionally, genes related to drug resistance and stemness were overexpressed in distal margins versus normal tissue. While CSC presence did not impact survival rates, the results suggest CSCs in surgical margins may drive tumor recurrence and wider margins could help reduce recurrence risk
The document discusses molecular subtyping of breast cancer through gene expression profiling which has identified major subtypes including luminal A, luminal B, HER2-enriched, and basal-like. It describes the characteristic gene expressions and clinical features of each subtype. Molecular subtyping is shown to have prognostic and predictive relevance for breast cancer outcomes and treatment responses.
Cancer recognition from dna microarray gene expression data using averaged on...IJCI JOURNAL
Cancer is a major leading cause of death and responsible for around 13% of all deaths world-wide. Cancer
incidence rate is growing at an alarming rate in the world. Despite the fact that cancer is preventable and
curable in early stages, the vast majority of patients are diagnosed with cancer very late. Therefore, it is of
paramount importance to prevent and detect cancer early. Nonetheless, conventional methods of detecting
and diagnosing cancer rely solely on skilled physicians, with the help of medical imaging, to detect certain
symptoms that usually appear in the late stages of cancer. The microarray gene expression technology is a
promising technology that can detect cancerous cells in early stages of cancer by analyzing gene
expression of tissue samples. The microarray technology allows researchers to examine the expression of
thousands of genes simultaneously. This paper describes a state-of-the-art machine learning based
approach called averaged one-dependence estimators with subsumption resolution to tackle the problem of
recognizing cancer from DNA microarray gene expression data. To lower the computational complexity
and to increase the generalization capability of the system, we employ an entropy-based geneselection
approach to select relevant gene that are directly responsible for cancer discrimination. This proposed
system has achieved an average accuracy of 98.94% in recognizing and classifyingcancer over 11
benchmark cancer datasets. The experimental results demonstrate the efficacy of our framework.
The role of Hysterectomy on BRCA mutation carriersValentina Cará
Hysterectomy may reduce the risk of uterine cancer for BRCA mutation carriers taking tamoxifen, by allowing estrogen-only hormone therapy and eliminating the uterine cancer risk from tamoxifen. However, the risks of hysterectomy, such as surgical complications, need to be weighed against the uncertain increased uterine cancer risk from tamoxifen. Studies have found both increased and similar uterine cancer rates in BRCA carriers taking tamoxifen compared to the general population. The decision to perform hysterectomy should be individualized based on risk factors and treatment options.
Cancer stem cell theory and evidence from colorecatalKareem Ahmed
This is a presentation of a review article explaining theory of cancer stem cells with evidences from colorectal cancer at a glance. It was presented at Student Research Symposium at Faculty OF Medicine, Assiut University, Assiut, Egypt,
Genetic polymorphisms of CYP3A41B of cervical cancer patients in Bangladeshi ...Md. Saifuzzaman
This study examined genetic polymorphisms of CYP3A4*1B in cervical cancer patients in Bangladesh. Thirty cervical cancer patients and 30 healthy controls were analyzed. The polymorphic frequencies of CYP3A4*1B allele were not significantly different between patients and controls. Specifically, the normal homozygote was 60% in patients and 66.67% in controls, the heterozygote was 40% in patients and 33.33% in controls. The mutant homozygote was 0% in both groups. The results suggest CYP3A4*1B polymorphism is not associated with increased risk of developing cervical cancer in the Bangladeshi population studied.
Epidemiologic Classification of Human Papillomavirus Types Associated with Ce...Alberto Cuadrado
background
Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but
the risk associated with the various HPV types has not been adequately assessed.
methods
We pooled data from 11 case–control studies from nine countries involving 1918 women
with histologically confirmed squamous-cell cervical cancer and 1928 control women.
A common protocol and questionnaire were used. Information on risk factors was
obtained by personal interviews, and cervical cells were collected for detection of HPV
DNA and typing in a central laboratory by polymerase-chain-reaction–based assays
(with MY09/MY11 and GP5+/6+ primers).
results
HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent)
and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV
DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The
most common HPV types in patients, in descending order of frequency, were types 16,
18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and
33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio
for cervical cancer associated with the presence of any HPV was 158.2 (95 percent
confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common
and least common HPV types. Fifteen HPV types were classified as high-risk types
(16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable
high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40,
42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic
classification and the classification based on phylogenetic grouping.
conclusions
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73,
and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66
should be considered probably carcinogenic.
This document summarizes three papers on population genetics and genomics research in African populations. The first paper discusses the African Genome Variation Project, which characterized genetic diversity in Africa and improved genomic studies on the continent. The second paper reviews pharmacogenetics studies in African populations, finding relatively few but highlighting their importance. The third paper summarizes prostate cancer genome-wide association studies, including initial studies identifying risk loci and more recent work identifying additional variants in African populations.
The document provides an overview of the history and development of oncology. It discusses how cancer was first documented in ancient Egypt and treated by cauterization. It then covers key developments like Hippocrates naming cancer, the first autopsy being performed in 1761, and the establishment of the TNM staging system. The summary concludes by briefly mentioning common modern cancer treatment modalities like surgery, radiation therapy, chemotherapy, and their goals of cure, palliation, or prevention.
Histopathological Patterns of Germ Cell Tumours of Ovary in a Tertiary Level ...inventionjournals
This document summarizes research on histopathological patterns of germ cell tumors of the ovary. The study found that benign cystic teratomas (dermoid cysts) made up the highest percentage at 26.47%, followed by dysgerminoma at 1.96%, immature teratoma at 0.98%, and yolk sac tumor at 0.98%. Germ cell tumors are more common in younger patients and can be benign or malignant. The histopathological patterns and characteristics of various germ cell tumors are described, including dysgerminoma, yolk sac tumor, embryonal carcinoma, polyembryoma, choriocarcinoma, and teratomas. Tumor markers such
This document summarizes research on Cadm1, a gene that suppresses metastasis. Genetic analysis identified a locus on mouse chromosome 9 associated with metastasis. Cadm1 was validated as a metastasis-suppressing gene within this locus. Ectopic expression of Cadm1 reduced pulmonary metastasis in vivo, while knockdown increased metastasis. Cadm1 expression was associated with better survival in human breast cancer datasets. The mechanism of Cadm1's effect involves interaction with the cell-mediated immune system through proteins like CRTAM that activate CD8+ T cells and NK cells, reducing metastasis in an immune-dependent manner.
We describe a comprehensive genomic characterization of 91 adrenocortical carcinoma specimens. Analysis identified several new ACC driver genes including PRKAR1A, RPL22, TERF2, CCNE1, and NF1. Genome-wide analysis revealed frequent occurrence of massive DNA loss followed by whole-genome doubling (WGD), associated with aggressive disease. WGD was identified as a hallmark of ACC progression, supported by increased TERT expression, decreased telomere length, and cell-cycle activation. Integrated molecular subtyping identified three ACC subtypes with distinct clinical outcomes and alterations, which could be captured by a 68-CpG DNA-methylation signature for clinical stratification.
This study used high-density SNP microarrays to analyze chromosomal changes in 86 paired colorectal cancer and normal tissue samples from Bangladeshi patients. The researchers identified common regions of amplification on chromosomes 20q, 13q, 8q, and 5p and deletions on 18q, 17p, and 8p. They also detected mosaicism and different types of chromosomal abnormalities that could not be assessed by other methods. By matching genes in altered regions to drug databases, the researchers identified potential targeted therapies for personalized treatment based on a patient's cytogenetic profile. This represents an application of high-density SNP arrays for colorectal cancer cytogenetics and personalized treatment approaches.
The document discusses molecular testing for breast cancer. It describes how molecular testing can provide insights into breast cancer subtypes, predict response to treatments, and assess recurrence risk. Several molecular tests are discussed, including Oncotype DX, Mammaprint, Prosigna, and tumor sequencing to identify actionable mutations. Molecular profiling is becoming increasingly important for personalized prevention, diagnosis, and treatment of breast cancer.
Over the past century, cancer treatment and outcomes have significantly improved due to advances in chemotherapy, radiation therapy, screening, surgery, and targeted molecular therapies. Five-year survival rates for many cancers have doubled or tripled compared to the 1970s. Recent decades have seen the development of targeted drugs, genomic mapping, and vaccines to prevent certain cancers. There are now over 13 million cancer survivors in the US, compared to just 3 million in the 1970s, demonstrating major gains against cancer.
This document summarizes a study that used DNA microarrays to analyze gene expression patterns in ovarian carcinomas. The key findings include:
1) The study identified groups of genes that distinguished clear cell ovarian carcinomas from other subtypes, and low-grade from high-grade serous papillary carcinomas.
2) Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas based on their gene expression patterns.
3) A comparison of ovarian carcinomas to breast cancers revealed 62 genes that correctly classified all 125 specimens, with genes like PAX8, mesothelin, and ephrin-B1 more highly expressed in ovarian carcinomas.
This document summarizes research targeting metastatic triple negative breast cancer using phage display nanotechnology. Key points:
- Triple negative breast cancer, which lacks estrogen, progesterone and HER2 receptors, has poor survival rates and few treatment options. The goal is to target cancer stem cells that initiate metastases.
- Phage display was used to select peptide sequences that bind specifically to triple negative breast cancer cells. Over 3 rounds of selection and amplification, binding peptides were increasingly enriched.
- Isolated phage clones were sequenced to identify binding peptide sequences for further development of targeted nanomedicines to treat metastatic triple negative breast cancer. Future work will modify pre-existing cancer nanomedicines with the selected peptides.
Breast cancer is the most common cancer among women in different societies. Because life is constructed evolutionary on the gravity of ‘g’, removed gravity as a variable can lead to clarify many biologic questions. Today, the weightlessness is a new method to study cellular changes. Weightlessness leads to metabolic and functional changes of the human body, and studies have shown that weightlessness leads to changes in growth and gene expression in cancer cells. The aim of this study is to evaluate the effect of weightlessness on apoptosis and cellular cycle in breast cancer cells. The tests of Annexin-V, PI-flow cytometer, and MTT have been used here. Cells of the weightlessness group are cultured on Clinostat prepared by the United Nations, and in gravity of 0.001g. The cell death and apoptosis using Annexin kit, and cell cycle using the PI and flow cytometer were investigated. Also, the amount of cell damage was determined by MTT. The apoptosis results showed that weightlessness leads to a reduction of 40% in apoptosis in cell line MCF-7, and the increase in BT-20 cell line for two times. Apoptosis in cell line MDA-MB-468 was not affected, and the results showed that the cell cycle and growth in cell line ZR-75 increased at a rate of five times (35% of weightlessness group versus 7% of control). Cell growth in the other categories showed no significant difference between two groups. Also, no significant difference was observed in the amounts of cell damage in groups of weightlessness and control.
The most complete map of oncogenes to date a summary of 568 oncogenes in 66 c...DoriaFang
By analyzing the genomes of 28,076 tumor samples from 66 types of cancer, 568 cancer driver genes were identified. This is the most complete map of cancer driver genes to date. The research data has been updated on the IntOGen platform.
Cord Blood Mesenchymal Stem Cells Conditioned Media Suppress Epithelial Ovari...ijtsrd
MSC CM suppresses epithelial ovarian cancer cells in vitro in a concentration-dependent manner. When ovarian cancer cells were treated with MSC CM at concentrations of 100%, 75%, 50%, and 25% for 72 hours, cell morphology changes were observed including cell shrinkage, debris and reduced cell numbers compared to control. MTT assays showed reduced proliferation and Annexin V testing demonstrated increased early and late apoptosis. Cell cycle analysis found an increased sub-G1 phase, indicating apoptosis. Expression of embryonic stemness genes was also progressively suppressed in cancer cells treated with MSC CM compared to control. Therefore, MSC CM has potential as an ovarian cancer inhibitor by creating new treatment modalities.
The study compared gene expression profiles between breast and prostate tumor stromas using microarray data and gene set enrichment analysis (GSEA). GSEA identified pathways that were commonly up-regulated or down-regulated in both tumor stromas, as well as pathways that were differentially regulated between them. Specifically, 9 pathways showed common regulation, while others like ABC transporters and oxidative phosphorylation differed in their regulation between tumor types. Certain genes and transcription factors also demonstrated heterogeneous expression patterns between breast and prostate tumor stroma. The results reveal genomic heterogeneity between tumor microenvironments and identify candidate signatures relevant to cancer progression.
The study aimed to analyze the molecular profiles of surgical margins and colorectal cancer (CRC) tumors to identify prognostic markers. The results showed that cancer stem-like cells (CSCs) were present in 84.84% of tumors but also enriched in the distal surgical margin in 63.63% of cases. CSCs in distal margins correlated with shorter resection lengths, with 81.8% of margins under 2cm positive for CSCs compared to 0% over 5cm. Additionally, genes related to drug resistance and stemness were overexpressed in distal margins versus normal tissue. While CSC presence did not impact survival rates, the results suggest CSCs in surgical margins may drive tumor recurrence and wider margins could help reduce recurrence risk
The document discusses molecular subtyping of breast cancer through gene expression profiling which has identified major subtypes including luminal A, luminal B, HER2-enriched, and basal-like. It describes the characteristic gene expressions and clinical features of each subtype. Molecular subtyping is shown to have prognostic and predictive relevance for breast cancer outcomes and treatment responses.
Cancer recognition from dna microarray gene expression data using averaged on...IJCI JOURNAL
Cancer is a major leading cause of death and responsible for around 13% of all deaths world-wide. Cancer
incidence rate is growing at an alarming rate in the world. Despite the fact that cancer is preventable and
curable in early stages, the vast majority of patients are diagnosed with cancer very late. Therefore, it is of
paramount importance to prevent and detect cancer early. Nonetheless, conventional methods of detecting
and diagnosing cancer rely solely on skilled physicians, with the help of medical imaging, to detect certain
symptoms that usually appear in the late stages of cancer. The microarray gene expression technology is a
promising technology that can detect cancerous cells in early stages of cancer by analyzing gene
expression of tissue samples. The microarray technology allows researchers to examine the expression of
thousands of genes simultaneously. This paper describes a state-of-the-art machine learning based
approach called averaged one-dependence estimators with subsumption resolution to tackle the problem of
recognizing cancer from DNA microarray gene expression data. To lower the computational complexity
and to increase the generalization capability of the system, we employ an entropy-based geneselection
approach to select relevant gene that are directly responsible for cancer discrimination. This proposed
system has achieved an average accuracy of 98.94% in recognizing and classifyingcancer over 11
benchmark cancer datasets. The experimental results demonstrate the efficacy of our framework.
The role of Hysterectomy on BRCA mutation carriersValentina Cará
Hysterectomy may reduce the risk of uterine cancer for BRCA mutation carriers taking tamoxifen, by allowing estrogen-only hormone therapy and eliminating the uterine cancer risk from tamoxifen. However, the risks of hysterectomy, such as surgical complications, need to be weighed against the uncertain increased uterine cancer risk from tamoxifen. Studies have found both increased and similar uterine cancer rates in BRCA carriers taking tamoxifen compared to the general population. The decision to perform hysterectomy should be individualized based on risk factors and treatment options.
Cancer stem cell theory and evidence from colorecatalKareem Ahmed
This is a presentation of a review article explaining theory of cancer stem cells with evidences from colorectal cancer at a glance. It was presented at Student Research Symposium at Faculty OF Medicine, Assiut University, Assiut, Egypt,
Genetic polymorphisms of CYP3A41B of cervical cancer patients in Bangladeshi ...Md. Saifuzzaman
This study examined genetic polymorphisms of CYP3A4*1B in cervical cancer patients in Bangladesh. Thirty cervical cancer patients and 30 healthy controls were analyzed. The polymorphic frequencies of CYP3A4*1B allele were not significantly different between patients and controls. Specifically, the normal homozygote was 60% in patients and 66.67% in controls, the heterozygote was 40% in patients and 33.33% in controls. The mutant homozygote was 0% in both groups. The results suggest CYP3A4*1B polymorphism is not associated with increased risk of developing cervical cancer in the Bangladeshi population studied.
Epidemiologic Classification of Human Papillomavirus Types Associated with Ce...Alberto Cuadrado
background
Infection with human papilloma virus (HPV) is the main cause of cervical cancer, but
the risk associated with the various HPV types has not been adequately assessed.
methods
We pooled data from 11 case–control studies from nine countries involving 1918 women
with histologically confirmed squamous-cell cervical cancer and 1928 control women.
A common protocol and questionnaire were used. Information on risk factors was
obtained by personal interviews, and cervical cells were collected for detection of HPV
DNA and typing in a central laboratory by polymerase-chain-reaction–based assays
(with MY09/MY11 and GP5+/6+ primers).
results
HPV DNA was detected in 1739 of the 1918 patients with cervical cancer (90.7 percent)
and in 259 of the 1928 control women (13.4 percent). With the GP5+/6+ primer, HPV
DNA was detected in 96.6 percent of the patients and 15.6 percent of the controls. The
most common HPV types in patients, in descending order of frequency, were types 16,
18, 45, 31, 33, 52, 58, and 35. Among control women, types 16, 18, 45, 31, 6, 58, 35, and
33 were the most common. For studies using the GP5+/6+ primer, the pooled odds ratio
for cervical cancer associated with the presence of any HPV was 158.2 (95 percent
confidence interval, 113.4 to 220.6). The odds ratios were over 45 for the most common
and least common HPV types. Fifteen HPV types were classified as high-risk types
(16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82); 3 were classified as probable
high-risk types (26, 53, and 66); and 12 were classified as low-risk types (6, 11, 40,
42, 43, 44, 54, 61, 70, 72, 81, and CP6108). There was good agreement between our epidemiologic
classification and the classification based on phylogenetic grouping.
conclusions
In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73,
and 82 should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66
should be considered probably carcinogenic.
Gene expression mining for predicting survivability of patients in earlystage...ijbbjournal
After numerous breakthroughs in medicine, microbiology, and pathology in the past century, lung cancer
still remains as a leading cause of cancer-related death even in the developed countries. Lung cancer
accounts roughly for 30% of all cancer-related deaths in the world. Diagnosis and treatments are still
based on traditional histopathology. It is of paramount importance to predictthe survivability of patients in
early stages oflung cancer so that specific treatments can be sought. Nonetheless, histopathology has been
shown by previous studies to be inadequate in predicting lung cancerdevelopment and clinical outcome.
The microarray technology allows researchers to examine the expression of thousands of genes
simultaneously. This paper describes a state-of-the-art machine learning based approach called averaged
one-dependence estimators with subsumption resolution to tackle the problem of predictingwhether a
patient in early stages of lung cancer will survive by mining DNA microarray gene expression data. To
lower the computational complexity, we employ an entropy-based geneselection approach to select relevant
genes that are directly responsible for lungcancer survivability prognosis. The proposed system has
achieved an average accuracy of 92.31% in predicting lung cancer survivability over 2 independent
datasets. The experimental results provide confirmation that gene expression mining can be used to predict
survivability of patients in earlystages of lung cancer.
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...semualkaira
anal squamous cell carcinoma (ASCC) is a relatively rare malignancy ac-counting for about 2-3% of all the gastrointestinal tumors. The standard of treatment for localized disease is chemoradiotherapy
Sex-Based Difference in Gene Alterations and Biomarkers in Anal Squamous Cell...semualkaira
anal squamous cell carcinoma (ASCC) is a relatively rare malignancy ac-counting for about 2-3% of all the gastrointestinal tumors. The standard of treatment for localized disease is chemoradiotherapy. Several studies reported a sex disparity
in ASCC prognosis showing a better survival for female compared
to men. Methods: we examined 1,380 patients with ASCC who received comprehensive genomic profiling as part of routine clinical
care and present key
Molecular Detection of Epstein Barr Virus, Human Papilloma Virus Types 16,18 ...CrimsonpublishersCancer
This study investigated the presence of Epstein Barr virus (EBV) and human papillomavirus (HPV) types 16 and 18 in breast cancer patients in Khartoum State, Sudan. DNA was extracted from paraffin-embedded tumor specimens from 70 breast cancer patients and tested for EBV and HPV using PCR. The results showed that 8 patients (11.4%) were positive for EBV and 7 patients (10%) were positive for HPV type 18, but none were positive for HPV type 16. This provides evidence that EBV and HPV type 18 may play a role in breast cancer in this population. The findings help establish baseline data on viral causes of breast cancer in Sudan and highlight the need for improved
This document discusses molecular profiling of breast cancer. It begins by introducing breast cancer as the most common cancer in women. It then discusses traditional classifications based on histological and clinical features. However, up to half of hormone receptor positive cancers do not respond to treatment, showing clinical classifications are insufficient. Molecular profiling uses high-throughput techniques to better understand breast cancer biology and refine classifications. Gene expression profiling has identified major molecular subtypes, like luminal A/B, HER2-positive, and basal-like. Multigene assays provide prognostic and predictive information beyond traditional clinics-pathological factors. Several common assays are discussed, including Oncotype DX, Mammaprint, and PAM50. Next generation sequencing is also discussed for
This research article examines the expression of RhoA and Rac1 in fibroblasts found at primary breast tumor sites and corresponding lymph node metastases. Immunohistochemistry on tissue microarrays revealed that 59% of fibroblasts at primary tumors and 41% at lymph node metastases expressed RhoA. Similarly, 57.1% at primary tumors and 42.9% at lymph node metastases expressed Rac1. Since expression levels were similar between primary and metastatic sites, the researchers suggest that fibroblasts actively participate in cancer cell invasion to lymph nodes and that metastatic cells continue relying on their microenvironment. Primary cell cultures were used to validate differences in focal adhesion pathways between carcinoma-associated fibroblasts and normal fibroblasts previously found via genomic profiling.
Histopathological patterns of cutaneous malignant melanoma in Sudaniosrjce
This study aimed to determine the histopathological patterns of cutaneous malignant melanoma in Sudanese patients. The study found that males represented 57.1% of cases and the majority of lesions (81.6%) were on the lower limbs. The most common clinic-pathological type was acral-lentiginous melanoma (75.5%). Microscopy showed epithelioid cell type in 61.2% of cases and deep invasion, ulceration, and lymphovascular invasion were common, indicating late stage at presentation. The findings were similar to previous studies in other African populations.
Michael's IUCRL Poster 2014 Close to Final with CDW editsMichael Araya
1) The study analyzed gene expression data from The Cancer Genome Atlas to identify genes that correlate with Amot in breast cancer and AmotL2 in thyroid cancer.
2) Pathway analysis revealed several cancer-related pathways that covaried with Amot levels in breast cancer, including Wnt signaling and TGF-beta signaling.
3) Genes that positively correlated with Amot in breast cancer and negatively correlated with AmotL2 in thyroid cancer were enriched for those involved in tumor growth, metastasis, and cancer stem cells.
Whiteman et al-1998-international_journal_of_cancerSilvina Verna
This study investigated the relationship between p53 expression and risk factors for cutaneous melanoma using a case-control study design. Tissue samples from 121 melanoma cases were analyzed for p53 expression using immunohistochemistry. Abnormal p53 expression was detected in 22 samples (18%). Risk factors for p53-positive melanoma included an inability to tan and history of non-melanoma skin cancer. Risk factors for p53-negative melanoma included high nevus count and heavy freckling. The results suggest there may be two pathways in melanoma pathogenesis characterized by p53 overexpression related to chronic sun exposure and pigment cell instability.
hMSH2 Gly322Asp (rs4987188) Single nucleotide polymorphism and the risk of br...Agriculture Journal IJOEAR
Aim: Breast cancer is the most common cancer in women both in the developed and less developed world. The reported study was designed to explore associations between hMSH2 - Gly322Asp (1032G>A, rs4987188) single nucleotide polymorphism (SNP) and the risk of breast carcinoma in the Polish women.
Material and methods: Blood samples were obtained from women with breast cancer (n=225), treated at the Department of Oncological Surgery and Breast Diseases, Polish Mother’s Memorial Hospital – Research Institute between the years 2005 and 2012. A control group included 220 cancer-free women. Genomic DNA was isolated and the SNP Gly322Asp of hMSH2 was determined by High-Resolution Melter method. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele.
Results: This study revealed that single nucleotide polymorphism Gly322Asp of hMSH2 is associated with both breast cancer risk and grading. Moreover, it can be linked with breast carcinoma tumor size and lymph node status. The Asp allele in patients may be a risk factor for breast carcinoma (OR 5.12; 95% CI 3.77 –6.97, p<.0001).
Conclusions: Gly322Asp single nucleotide polymorphism of hMSH2 may be a risk factor of breast cancer in the Polish women.
This document summarizes genetic changes in endometrial cancer and Lynch syndrome (HNPCC). It discusses two types of endometrial cancer (Type I and Type II), risk factors, molecular features, diagnosis of Lynch syndrome, cancer risks, pathogenesis, tests used for screening/diagnosis including immunohistochemistry and microsatellite instability testing. Lynch syndrome is an autosomal dominant condition associated with mutations in mismatch repair genes that increases risks of colorectal, endometrial and other cancers.
This document describes a study investigating the role of the protein Morgana in breast cancer metastasis. The study found that knocking down Morgana impaired migration, invasion, and metastasis of breast cancer cells in vitro and in vivo. Mechanistically, Morgana was found to increase the transcriptional activity of NF-κB, leading to increased expression of metastasis-promoting genes like MMP-9. Overexpressing Morgana had the opposite effect of increasing NF-κB target gene expression. Therefore, Morgana appears to promote breast cancer metastasis by activating the NF-κB pathway and increasing expression of pro-metastatic genes.
This study examined promoter hypermethylation of the hmlh1 gene in esophageal cancer patients from Kashmir, India. The researchers collected tumor and normal tissue samples from 50 cancer patients and 20 controls. DNA was extracted from the samples and treated to detect methylation levels. Methylation-specific PCR was performed using methylated and unmethylated primers. The frequency of hmlh1 promoter hypermethylation was 56% in cancer tissues and 15% in normal tissues, which was a statistically significant difference. The results suggest aberrant hmlh1 promoter hypermethylation may play a role in esophageal carcinogenesis in this high-risk population.
This study aims to determine if there is a genetic ancestral link between Latinas diagnosed with triple negative breast cancer (TNBC) and their maternal ancestry. The researchers analyzed DNA samples from 100 Latinas, including 31 with TNBC, 34 with other types of breast cancer, and 35 healthy controls. They focused on the hypervariable region 1 (HVR1) of mitochondrial DNA, which can indicate maternal ancestry. Preliminary results from two cell lines suggest that a TNBC cell line has African maternal ancestry, while a non-TNBC cell line has European ancestry. The researchers expect to find higher rates of African maternal ancestry among the Latinas diagnosed with TNBC compared to the other groups. Identifying an ancestral link could help develop
This study compared genomic data from 39 HNSCC cell lines to genomic findings from 106 HNSCC tumors. Amplification of eight genes and deletion of five genes were found in both cell lines and tumors. Seventeen genes were only mutated in cell lines, suggesting these mutations arose in tissue culture. Conversely, 11 genes were only mutated in over 10% of tumors. Several mutant genes in the EGFR pathway were shared between cell lines and tumors. Pharmacologic profiling of six cell lines suggested PIK3CA mutation may predict sensitivity to EGFR/PI3K pathway drugs. These findings suggest correlating gene mutations between cell lines and tumors can guide selection of preclinical models.
Survival Analysis of Determinants of Breast Cancer Patients at Hossana Queen ...Premier Publishers
Breast cancer is one of the most severe diseases in the world and become the public’s ever day’s agenda in both developed and developing countries. The primary goal of this study was to identify the determinants of survival time of breast cancer patients at Hossana hospital, south Ethiopia. Kaplan-Meier estimation method and a new two-parameter probability distribution called hypertabastic are introduced to model the survival time of the data. A simulation study was carried out to evaluate the performance of the hypertabastic distribution in comparison with popular distribution with the help of R and SAS statistical software Packages. One-fourth (25%) of the total patients survived for only 2 days. 31(35.2%) were censored, and 55(62.5%) were died. Hypertabastic survival model was found to be best fitting to the breast cancer data and age, level of education, family history, breast problem before, High fat diet, child late age, early menarche, late menopause were significant risk factors for the death of breast cancer patients. Awareness has to be given for the society on causes of breast cancer and screening test and early detection policies for most risky groups has to be established.
Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer S...ijtsrd
BACKGROUND Invasive Cervical Cancer ICC has been identified as the second most common cause of morbidity and mortality compared to other cancers among women in Cameroon. Cervical cancer can be treated e ectively if diagnosed early. Less than half the number of participants presented with good practice.The correlation between participants’ knowledge, attitude and practice showed that there was a significant association which therefore provides sufficient evidence to reject the null hypothesis. The result obtained in this study indicates how useful it will be to establish health education programs to increase women’s awareness and knowledge about cervical cancer. Fongang Che Landis | Enow-Orock George | Njajou Omer | Ngowe Ngowe Marcelin "Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer Screening and Its Associated Factors among Women in the City of Bamenda, Cameroon" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43667.pdf Paper URL: https://www.ijtsrd.commedicine/other/43667/knowledge-attitude-and-practice-toward-cervical-cancer-and-cervical-cancer-screening-and-its-associated-factors-among-women-in-the-city-of-bamenda-cameroon/fongang-che-landis
This document provides guidelines for the management of endometrial cancer from several European medical societies. It covers epidemiology, risk assessment, surgery, lymph node staging, adjuvant therapy, and management of early, advanced, and recurrent disease. Key points include recommending total hysterectomy and bilateral salpingo-oophorectomy for staging without vaginal cuff resection for early-stage disease. It also supports consideration of sentinel lymph node biopsy for staging in select cases and ovarian preservation in certain low-risk premenopausal patients. Molecular testing is encouraged to further stratify prognosis, especially in high-grade tumors.
Similar to Breast Cancer Genetic Characteristics in North Africa: A Genome Wide Haplotype Study in the General Tunisian Population (20)
Concomitant infection with Mycoplasma pneumoniae and SARS-CoV-2 in Tunisian p...Pasteur_Tunis
This study investigated co-infection of Mycoplasma pneumoniae in 13 COVID-19 patients in Tunisia. Serological testing found that 9 of the 13 patients (69%) were positive for M. pneumoniae infection at the same time as SARS-CoV-2. These results were confirmed through three diagnostic assays. This is the first report of potential co-infection with M. pneumoniae in COVID-19 patients in Tunisia. Further research with larger sample sizes is needed.
In vivo investigation of the genotoxic potential of C17-Sphinganine analog my...Pasteur_Tunis
This study evaluated the genotoxic potential of C17-Sphinganine analog mycotoxin (C17-SAMT) in mice using comet assays, a micronucleus test, and histopathological analysis of the liver. The comet assays showed a statistically significant increase in DNA damage in the livers of mice treated with 300 μg/kg of C17-SAMT but not in the duodenum or spleen. The micronucleus test found no increase in micronuclei in bone marrow. Microscopic examination of the liver revealed increased mitosis and hepatocyte cytoplasm clarification. The study confirms DNA damage in the liver from C17-SAMT but found no evidence
Le séquençage haut débit: NGS, une révolution de la biologie moléculaire au s...Pasteur_Tunis
Présentation de MALLEK Ramdane
rmallek@lab-cerba.com
Biologie Moléculaire et génomique, Laboratoire Cerba, Saint-Ouen l'Aumône, France
Institut Pasteur de Tunis 6 Avril 2019
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Kat...rightmanforbloodline
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
TEST BANK For Basic and Clinical Pharmacology, 14th Edition by Bertram G. Katzung, Verified Chapters 1 - 66, Complete Newest Version.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Breast Cancer Genetic Characteristics in North Africa: A Genome Wide Haplotype Study in the General Tunisian Population
1. Breast Cancer Genetic Characteristics in North Africa: A Genome Wide
Haplotype Study in the General Tunisian Population
Yosr Hamdi1, Mariem ben Rekaya1, Najah Mighri1, Maroua Boujemaa1, Soumaya Labidi11,2, Jingxuan Shan3, Majdi Nagara1, Lotfi Chouchane3, Sonia Abdelhak1, Lilia Romdhane1,4, Hamouda
Boussen2, on the bahalf of the PEC Consortium2 .
1 Laboratoire de Génomique Biomédicale et Oncogénétique Institut Pasteur de Tunis, Université de Tunis El Manar
2 Service d’Oncologie Medicale Hopital Abdel Rahmen Mami Ariana
3 Department of Genetic Medicine, Weill Cornell Medical College-Qatar, Doha, Qatar
4 Department of Biology, Faculty of Science of Bizerte, Université Tunis Carthage, Tunisia
The vast majority of breast cancer genetic variations reported to date are from populations with European ancestry. Because of different linkage disequilibrium
patterns, important differences in genetic architecture have been observed between ethnicities. Moreover, the major challenge of breast cancer molecular genetics
is to identify causal variants. Thus, association studies and haplotype analysis in different populations can help to overcome this challenge. In this study, we
investigated the genetic architecture of several common variants in the Tunisian population and we compared their characteristics in different ethnic groups. We
characterized rs9911630-BRCA1 as a putative functional SNP that seems to affect the expression levels of BRCA1 and NBR2 genes in a cis-miR-eQTL manner.
We performed a genome-wide haplotype study by genotyping a set of
135 Tunisian individuals from the general population using the Affymetrix
6.0-Array in order to investigate the genetic characteristics of several
common variants known to be associated with breast cancer risk. We
phased haplotypes and constructed LD-blocks. We also performed Principle
Component Analysis based on 79 breast cancer associated variants. Finally,
We assessed the putative function of some selected variants using in silico
prediction tools and by conducting eQTL-assays .
Abstract
Methods
Haplotype analysis showed that Tunisians are more predisposed to
breast cancer variants on 2p24, 4q21, 6q25, 9q31, 10q26, 11q13 and
14q32 loci (Fig.1). We also identified 4 polymorphisms (rs2046210,
rs941764, rs3803662, and rs13329835) that showed significant frequency
differences between Tunisians and 11 populations from European, Asian
and African origins. Moreover, our PCA-plots and LD-blocks showed that
the genetic characteristics of breast cancer common variants in the
Tunisian population are similar to those of European populations (Fig.2).
Results
Population genetics:
Functional Analysis:
We explored the functional role of 79 breast cancer common variants.
rs9911630-BRCA1 get the highly ranked RegulomeDB score (1b).
Interestingly, rs9911630 is also the most strongly expression-associated
variant and the highly significant eQTL evidence was associated with NBR2
gene (p =1.2x10-23). Using the Genevar platform, we assessed eQTL
associations for rs9911630 in 8 populations. Data showed that rs9911630 is
significantly associated with the expression level of BRCA1 gene in Asian
and Caucasian populations but not in Africans (Fig.3). Consequently, we
compared the allelic frequencies of rs9911630 between different
populations. The frequency of rs9911630 is significantly different between
African populations on one side and Europeans, Asian and Tunisian
populations on another side (Table 1). Finally, We performed in silico
predictions of micro RNA binding sites using mirBase. Results showed that
rs9911630 causes a gain of mse-miR-2766 binding site and the loose of
bmo-miR3287 and ssa-miR-19d-5p binding sites.
Conclusion
This Population genetic analysis was usefull to compare the genetic
architecture of several common variants in several ethnic groups and to
identify a putative breast cancer causal variant on the BRCA1 gene in a cis-
miR-eQTL manner. The observed discordance in the genetic background
between populations highlights the necessity to establish a specific
genotype profile for each population. Therefore, caution should be
exercised when applying any genetic risk prediction model based on
tagSNPs outside of the ancestry group in which it was derived.
Figure 1. Distribution of breast cancer at risk
haplotypes in the general Tunisian population.
Figure 3. eQTL analysis of the rs9911630- BRCA1 variant in different populations.
Figure 2. Principle component analysis.
CEU TSI CHB JPT MEX CHD GIH TUN ASW MKK LWK YRI
MAF 0,336 0,392 0,327 0,273 0,25 0,435 0,477 0,426 0,623 0,535 0,728 0,795
Minor
allele
G G G G G G G G A A A A
Table 1. Comparison of rs9911630 frequencies between different populations.
Africans
Asians
Europeans